Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001801198-25-000012
Filing Date
2025-03-11
Accepted
2025-03-11 16:02:47
Documents
240
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F legn-20241231.htm   iXBRL 20-F 4017816
2 EX-2.4 exhibit2_41.htm EX-2.4 185156
3 EX-4.4 exhibit4_41.htm EX-4.4 20893
4 EX-4.8 exhibit4_81.htm EX-4.8 144168
5 EX-4.9 exhibit4_91.htm EX-4.9 164049
6 EX-4.11 exhibit4_111.htm EX-4.11 10561
7 EX-4.23 exhibit4_231.htm EX-4.23 16019
8 EX-4.24 exhibit4_241.htm EX-4.24 678525
9 EX-4.25 exhibit4_251.htm EX-4.25 47421
10 EX-4.26 exhibit4_261.htm EX-4.26 18464
11 EX-4.27 exhibit4_271.htm EX-4.27 441862
12 EX-4.28 exhibit4_281.htm EX-4.28 22403
13 EX-4.29 exhibit4_291.htm EX-4.29 18728
14 EX-4.30 exhibit4_302.htm EX-4.30 24610
15 EX-8.1 exhibit8_11.htm EX-8.1 3919
16 EX-11.1 exhibit11_11.htm EX-11.1 185228
17 EX-11.2 exhibit11_21.htm EX-11.2 79387
18 EX-12.1 exhibit12_11.htm EX-12.1 10577
19 EX-12.2 exhibit12_21.htm EX-12.2 10548
20 EX-13.1 exhibit13_11.htm EX-13.1 4685
21 EX-13.2 exhibit13_21.htm EX-13.2 5224
22 EX-15.1 exhibit15_11.htm EX-15.1 4113
28 footer.jpg GRAPHIC 5863
29 image.jpg GRAPHIC 44257
30 image1.jpg GRAPHIC 193947
31 image2.jpg GRAPHIC 17954
32 image2a.jpg GRAPHIC 279385
33 image53.jpg GRAPHIC 4729
34 image_0.jpg GRAPHIC 201
35 image_0b.jpg GRAPHIC 56673
36 image_3.jpg GRAPHIC 117820
37 image_6.jpg GRAPHIC 492453
38 image_7.jpg GRAPHIC 314248
39 image_8.jpg GRAPHIC 534265
40 image_81.jpg GRAPHIC 3193
41 image_9.jpg GRAPHIC 465190
42 legn-20241231_g1.jpg GRAPHIC 166615
43 legn-20241231_g10.jpg GRAPHIC 171949
44 legn-20241231_g11.jpg GRAPHIC 120315
45 legn-20241231_g12.jpg GRAPHIC 85203
46 legn-20241231_g13.jpg GRAPHIC 203653
47 legn-20241231_g14.jpg GRAPHIC 70921
48 legn-20241231_g15.jpg GRAPHIC 80025
49 legn-20241231_g16.jpg GRAPHIC 101329
50 legn-20241231_g17.jpg GRAPHIC 59918
51 legn-20241231_g18.jpg GRAPHIC 104056
52 legn-20241231_g19.jpg GRAPHIC 95865
53 legn-20241231_g2.jpg GRAPHIC 13588
54 legn-20241231_g20.jpg GRAPHIC 140873
55 legn-20241231_g21.jpg GRAPHIC 130823
56 legn-20241231_g22.jpg GRAPHIC 148600
57 legn-20241231_g23.jpg GRAPHIC 214623
58 legn-20241231_g24.jpg GRAPHIC 190378
59 legn-20241231_g25.jpg GRAPHIC 155257
60 legn-20241231_g26.jpg GRAPHIC 215233
61 legn-20241231_g27.jpg GRAPHIC 180338
62 legn-20241231_g28.jpg GRAPHIC 212017
63 legn-20241231_g29.jpg GRAPHIC 183561
64 legn-20241231_g3.jpg GRAPHIC 10394
65 legn-20241231_g30.jpg GRAPHIC 168642
66 legn-20241231_g31.jpg GRAPHIC 156267
67 legn-20241231_g32.jpg GRAPHIC 253834
68 legn-20241231_g33.jpg GRAPHIC 194808
69 legn-20241231_g34.jpg GRAPHIC 202679
70 legn-20241231_g35.jpg GRAPHIC 194802
71 legn-20241231_g36.jpg GRAPHIC 158287
72 legn-20241231_g37.jpg GRAPHIC 76194
73 legn-20241231_g4.jpg GRAPHIC 190631
74 legn-20241231_g5.jpg GRAPHIC 231283
75 legn-20241231_g6.jpg GRAPHIC 172979
76 legn-20241231_g7.jpg GRAPHIC 220043
77 legn-20241231_g8.jpg GRAPHIC 244473
78 legn-20241231_g9.jpg GRAPHIC 93343
79 picture2.jpg GRAPHIC 5419
  Complete submission text file 0001801198-25-000012.txt   36574044

Data Files

Seq Description Document Type Size
23 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20241231.xsd EX-101.SCH 156381
24 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20241231_cal.xml EX-101.CAL 125759
25 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20241231_def.xml EX-101.DEF 514189
26 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20241231_lab.xml EX-101.LAB 1044781
27 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20241231_pre.xml EX-101.PRE 835182
242 EXTRACTED XBRL INSTANCE DOCUMENT legn-20241231_htm.xml XML 2793692
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-850-5598
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39307 | Film No.: 25727508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)